Antengene (HKSE:06996) Short-Term Capital Lease Obligation : HK$8.86 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Antengene Short-Term Capital Lease Obligation?

Antengene's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$8.86 Mil.

Antengene's quarterly Short-Term Capital Lease Obligation declined from Jun. 2023 (HK$12.28 Mil) to Dec. 2023 (HK$7.95 Mil) but then increased from Dec. 2023 (HK$7.95 Mil) to Jun. 2024 (HK$8.86 Mil).

Antengene's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (HK$13.32 Mil) to Dec. 2022 (HK$12.19 Mil) and declined from Dec. 2022 (HK$12.19 Mil) to Dec. 2023 (HK$7.95 Mil).

Antengene Short-Term Capital Lease Obligation Historical Data

The historical data trend for Antengene's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Short-Term Capital Lease Obligation Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

5.84

13.32

12.19

7.95

4.00

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial								12.19	12.28	7.95	8.86	4.00

Antengene Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Antengene Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Antengene's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (HKSE:06996) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

722:Germany

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Executives

Xyxy Holdings Ltd.	2201 Interest of corporation controlled by you
Boyu Group, Llc	2201 Interest of corporation controlled by you
Boyu Capital Group Holdings Ltd	2201 Interest of corporation controlled by you
Tong Xiaomeng	2201 Interest of corporation controlled by you
Jay Mei 2025 Grat	2201 Interest of corporation controlled by you
Mei Jay	2201 Interest of corporation controlled by you
Jay Mei 2023 Grat	2201 Interest of corporation controlled by you
Fountainvest China Capital Partners Gp3 Ltd.	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Fountainvest China Capital Partners Fund Iii, L.p.	2201 Interest of corporation controlled by you
Begonia Investment Ltd.	2101 Beneficial owner
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner

Antengene Headlines

No Headlines